Bath & Body Works (BBWI) AI Stock Analysis

Bath & Body Works

(BMV:BBWI)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong cash generationSubstantial operating and free cash flow gives BBWI internal funding for store, digital, and product investments while supporting shareholder returns. Strong cash conversion is a durable advantage, although leverage still limits how much of this cash can reduce financial risk.

Negative Factors

Highly leveraged balance sheetHigh debt combined with negative equity leaves BBWI more dependent on sustained cash generation and financing access than a company with a stronger capital base. Leverage can restrict investment flexibility and increase vulnerability if operating performance weakens.

Bath & Body Works (BBWI) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 4.68B
Dividend Yield: 3.47%
Average Volume (3M): 127
Price to Earnings (P/E): 6.2
Beta (1Y): 0.30
Revenue Growth: -11.86%
EPS Growth: 1.96%
Country: Mexico
Employees: 60,735
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Specialty Retail

Bath & Body Works Business Overview & Revenue Model

Company Description

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, ha...

Bath & Body Works Earnings Call Summary

Earnings Call Date:Aug 25, 2026(Q2-2026)|% Change Since:36.33%|Next Earnings Date:Nov 17, 2026

Earnings Call SentimentNeutral

The call showcased several meaningful tactical wins—Q2 results beat guidance, adjusted EPS outperformed and full-year EPS guidance was raised; digital returned to growth, Fruit Fusion demonstrated the new go-to-market playbook, and expanded distribution (Amazon, Ulta) scaled quickly. However, many of the upside results were aided by a one-time tariff refund and the underlying business remains pressured: store sales are down, body care is still underperforming, and full-year and Q3 revenue are still guided to declines. Management emphasized multiyear transformation and prudent investment, but near-term headwinds (tariffs, store traffic, margin deleverage) temper the optimism.

Positive Updates

Q2 Net Sales Ahead of Guidance

Net sales of $1.5 billion in Q2 declined 2.3% year-over-year but beat guidance (previously down 5% to down 3%), providing evidence of sequential improvement versus Q1.

Negative Updates

Underlying Business Pressure and Store Declines

U.S. and Canadian store net sales were $1.1 billion, down 5.4% YoY; management cited pressured store traffic and channel shift to direct (free ship $50) as headwinds—store performance remains a key challenge to restoring broad growth.

Company Guidance

Management narrowed full‑year net sales guidance to down 4.0% to down 2.5% and raised full‑year adjusted EPS to $2.60–$2.80 after Q2 outperformance (Q2 net sales $1.5B, down 2.3%; Q2 adjusted EPS $0.62, which included ≈$80M of tariff refunds that contributed ~530 bps to merchandise margin and would leave EPS ≈$0.31 ex‑refund). They now expect full‑year adjusted gross profit of ~43.3% (including the refund), adjusted SG&A rate ~29.6%, adjusted net non‑operating expense ≈$217M, adjusted tax rate ~26.8% and ~203M weighted average diluted shares; Q3 guidance is net sales down 5% to down 2.5%, gross profit ≈40%, SG&A ≈34.8%, adjusted net non‑operating expense ≈$54M, adjusted tax rate ≈26% and Q3 adjusted EPS $0.07–$0.12. Other updated metrics: capex ~$240M (YTD $98M), free cash flow ~$650M (up from $600M), Fuel for Growth savings ~ $200M (vs. $175M goal), $250M of 2029 notes redeemed, and management is accounting for ~ $30M (≈40 bps) of forward tariff/input cost pressure and ~$35M of incremental Consumer First Formula investments (about 70% of which are weighted to Q3).

Bath & Body Works Risk Analysis

Bath & Body Works disclosed 41 risk factors in its most recent earnings report. Bath & Body Works reported the most risks in the "Production" category.

Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Bath & Body Works Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

MX:BBWI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SBH	81Outperform	$1.70B	9.25	23.11%	―	1.08%	3.88%
ULTA	74Outperform	$27.38B	23.14	45.40%	―	11.16%	5.20%
BWMX	64Neutral	$664.14M	9.24	69.99%	7.26%	28.31%	43.42%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
MNSO	58Neutral	$3.07B	17.47	14.11%	6.39%	30.43%	-44.33%
TKLF	47Neutral	$6.35M	0.82	1.71%	13.59%	77.22%	-89.32%

* Consumer Cyclical Sector Average

Performance Comparison

MX:BBWI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:BBWI	Bath & Body Works, Inc.	409.00	-39.06	-8.72%
SBH	Sally Beauty Holdings	18.41	4.26	30.11%
ULTA	Ulta Beauty	637.57	120.91	23.40%
BWMX	Betterware De Mexico, S.A. De C.V	17.48	4.30	32.64%
MNSO	Miniso Group Holding Ltd.	10.42	-10.20	-49.46%
TKLF	Yoshitsu Co. Ltd. Sponsored ADR	1.39	-1.88	-57.49%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Bath & Body Works AI Stock Analysis